The Unfolding Story of Hope: BridgeBio's Double Victory in the Battle Against Rare Disease
A CRISPR Conundrum: Intellia's Trial Halt Jolts the Biotech World
Acoramidis: A Beacon of Hope for Rare Heart Disease Patients with Rapid Cardiac Benefit